Director Robert Hombach receives 2,577-share stock award at Henry Schein (HSIC)
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
HOMBACH ROBERT J. reported acquisition or exercise transactions in this Form 4 filing.
Henry Schein Inc. director Robert J. Hombach reported an equity award of 2,577 shares of common stock on March 6, 2026. These shares were granted under the company’s 2023 Non-Employee Director Stock Incentive Plan at no purchase price, increasing his directly held stake to 5,421 shares.
According to the award terms, the restricted stock units generally vest after a 12‑month cliff period, provided Mr. Hombach continues to perform services for Henry Schein. This filing reflects routine director compensation in the form of stock-based incentives.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
HOMBACH ROBERT J.
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock par value $0.01 per share | 2,577 | $0.00 | -- |
Holdings After Transaction:
Common Stock par value $0.01 per share — 5,421 shares (Direct)
Footnotes (1)
- [object Object]
FAQ
What did Henry Schein (HSIC) director Robert Hombach report in this Form 4?
Robert Hombach reported receiving 2,577 shares of Henry Schein common stock as an equity award. The grant increased his directly held position to 5,421 shares and represents routine non-employee director compensation under the company’s 2023 stock incentive plan.
What are the vesting terms for Robert Hombach’s Henry Schein (HSIC) stock award?
The award consists of restricted stock units that generally vest after a 12‑month cliff period. Vesting is subject to certain exceptions and requires Mr. Hombach’s continued performance of services for Henry Schein during that specified time period.
Was Robert Hombach’s Henry Schein (HSIC) Form 4 transaction a market purchase or sale?
The Form 4 shows a grant or award acquisition, not a market purchase or sale. The 2,577 shares were issued at a reported price of $0.00 per share as stock-based director compensation, rather than being bought or sold on the open market.